Physician profile
Eric J Venegas
NPI 1760485502
$518.17
in general payments reported to CMS, 2019-2025
11 companies · $73.77 in 2025
The $73.77 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.62 · 2021: $104 · 2023: $13.92 · 2024: $274 · 2025: $73.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $227 · Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $226.53 |
| Food and Beverage | $135.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $226.53 | 2024 | |
| Pfizer INC. | $69.64 | 2021 | |
| Hologic Sales and Service, LLC | $50.30 | 2019-2025 | Aptima |
| Abbvie INC. | $49.07 | 2021-2024 | Lo Loestrin Fe |
| Smith+Nephew, INC. | $22.74 | 2025 | Pico 7 |
| Bayer Healthcare Pharmaceuticals INC. | $20.97 | 2019 | |
| Astellas Pharma US INC | $17.44 | 2024 | Veozah |
| Allergan, INC. | $17.09 | 2019 | |
| Exact Sciences Corporation | $15.36 | 2024 | Cologuard Collection Kit |
| Organon LLC | $14.74 | 2021 | |
| Ethicon US, LLC | $14.29 | 2025 | Linx Reflux Management System, Echelon; Endopath, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Venegas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.